Restart Life Sciences Corp. (CSE:HEAL)
Canada · Delayed Price · Currency is CAD 0.1000
0.00 (0.00%)
Feb 25, 2026, 2:09 PM EST
Restart Life Sciences Market Cap
Restart Life Sciences has a market cap or net worth of CAD 5.93 million as of March 2, 2026. Its market cap has increased by 166.33% in one year.
Market Cap
5.93M
Enterprise Value
5.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since September 22, 2006, Restart Life Sciences's market cap has increased from 4.41M to 5.93M, an increase of 34.51%. That is a compound annual growth rate of 1.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 5.93M | -10.43% |
| Dec 31, 2025 | 6.62M | 512.13% |
| Dec 31, 2024 | 1.08M | -63.28% |
| Dec 29, 2023 | 2.94M | -79.49% |
| Dec 30, 2022 | 14.35M | 134.03% |
| Dec 31, 2021 | 6.13M | -74.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marvel Biosciences | 7.83M |
| COSCIENS Biopharma | 7.77M |
| Kane Biotech | 7.26M |
| Cytophage Technologies | 7.11M |
| BioVaxys Technology | 6.83M |
| PharmaTher Holdings | 6.83M |
| Aptose Biosciences | 5.51M |
| MYND Life Sciences | 5.22M |